Nantcell, INC.
Doing business as Nantcell INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersCulver City, CA
US patents41
SAM.gov UEIXLVDBMKZ3BA6
CAGE code8KZ23
Incorporated inDE
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
41 US patents granted 2021–2025, 41 of them in the five years to SEP 2025.
Pharmaceuticals 30Computer technology 6Measurement 4Medical technology 1
- Treatment of immunosuppressed subjectsUS 12,427,184 · granted SEP 30, 2025
- Targeted neoepitope vectors and methods thereforUS 12,311,018 · granted MAY 27, 2025
- Treatment of immunosuppressed subjectsUS 12,303,552 · granted MAY 20, 2025
- HIV treatment compositions and methodsUS 12,303,477 · granted MAY 20, 2025
- Fusion molecules of CTLA4 and IL-15US 12,297,247 · granted MAY 13, 2025
Newest 5 shown · Granted to NantCell, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Nantcell, INC. | Culver City | CA | — | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.